Bluegrass Vascular Technologies announced that it won FDA de novo clearance for its Surfacer inside-out access catheter system.
The Surfacer is designed to obtain central venous access through its inside-out approach, facilitating catheter insertion to the central venous system in people with upper body venous occlusions or other conditions that limit central venous access through conditional methods. The system could be especially beneficial for people who rely on dialysis but have obstructed vein problems.